2bind
Biotechnology ResearchBavaria, Germany11-50 Employees
2bind operates as a contract research organization serving the global drug discovery and preclinical development space. Based in Regensburg, Bavaria, Germany, it supports biotech and pharmaceutical innovators with services across small molecule drug discovery and early-stage antibody development. The company aims to provide data across discovery and optimization cycles to enable faster, more confident decision-making. For small molecules, 2bind offers end-to-end support from protein purification and hit identification to hit validation, hit-to-lead, and lead optimization. For antibodies and other biologics, it runs workflows that cover screening, lead selection, developability assessment, binding and functional characterization, as well as pre-formulation and storage stability studies, helping clients de-risk development. A recent development includes a partnership with CNATM to advance nucleic acid therapeutics research.
1-888-653-2347 
support@leadiq.com 
